期刊
NATURE CHEMICAL BIOLOGY
卷 10, 期 4, 页码 248-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/NCHEMBIO.1459
关键词
-
资金
- US National Institutes of Health [HL094463, GM102137, HL62244, HL096972, GM38060, HL096679, HL117659]
- US National Institutes of Health Research Training Grant [T32-HL007149]
- Royal Thai Government fellowship
Low-molecular-weight heparins (LMWHs) are carbohydrate-based anticoagulants clinically used to treat thrombotic disorders, but impurities, structural heterogeneity or functional irreversibility can limit treatment options. We report a series of synthetic LMWHs prepared by cost-effective chemoenzymatic methods. The high activity of one defined synthetic LMWH against human factor Xa (FXa) was reversible in vitro and in vivo using protamine, demonstrating that synthetically accessible constructs can have a critical role in the next generation of LMWHs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据